番红花苷
药理学
活性氧
生物相容性
化学
电离辐射
医学
辐照
生物化学
物理
有机化学
核物理学
作者
Lu Wang,Yu Cao,Xiaoyi Zhang,Haibo Liu,Jia Yin,Liangju Kuang,Weiwei He,Daoben Hua
标识
DOI:10.1016/j.colsurfb.2022.112441
摘要
With the progress of nuclear technology including radiotherapy and radiodiagnosis, radiation has been widely used in many fields as a powerful diagnostic and therapeutic tool in the medical area. Unfortunately, acute radiation disease will occur if the human body is accidentally exposed to a large dosage of ionizing radiation. However, clinical radioprotective agents are being challenged by the short half-life and several side effects. In this work, a reactive oxygen species-responsive nanodrug is developed for efficient radioprotection. The nanodrug was prepared by modifying Crocin-I with 4-pentylphenylboronic acid (PBA) and exhibited effective responsiveness and scavenging activity of reactive oxygen species. PBA-Crocin nanodrug displayed good biocompatibility and radioprotection effect compared to Crocin-I in vitro. The survival rate of cells treated with PBA-Crocin (10 μg mL-1) is comparable to that treated with amifostine (12.5 μg mL-1, the only radioprotector approved by the United States Food and Drug Administration clinically) after 6 Gy irradiation. Importantly, PBA-Crocin resulted in markedly prevention of radiation-induced damage in peripheral blood cells and a 1.6-fold longer retention time of Crocin-I in plasma in comparison with Crocin-I. The finding suggests a new design for natural medicine in effective radioprotection.
科研通智能强力驱动
Strongly Powered by AbleSci AI